Astrana Health, Inc. reports results for the quarter ended June 30 - Earnings Summary

Astrana Health

07/08/2026 03:35

Astrana Health, Inc. ASTH.OQ reported quarterly adjusted earnings of 40 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 19 cents.  The mean expectation of ten analysts for the quarter was for earnings of 34 cents per share. Wall Street expected results to range from 26 cents to 39 cents per share.
Revenue rose 48.5% to $972.52 million from a year ago; analysts expected $985.65 million. 
Astrana Health, Inc.'s reported EPS for the quarter was 40 cents​.
The company reported quarterly net income of $19.74 million.
Astrana Health, Inc. shares had fallen by 22.8% this quarter and gained 44.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.4% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy" 
Wall Street's median 12-month price target for Astrana Health, Inc. is $50.00, about 31.7% above its last closing price of $34.13
This summary was machine generated from LSEG data August 7 at 02:35 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.34
0.40
Beat
Mar. 31 2026 
0.30
0.29
Missed
Dec. 31 2025 
0.11
0.12
Beat
Sep. 30 2025 
0.44
0.01
Missed